Your browser doesn't support javascript.
loading
Effectiveness of calcipotriol/betamethasone dipropionate aerosol foam in patients with small versus large plaque psoriasis in routine practice in South Korea.
Jo, Seong Jin; Park, Chul-Jong; Bang, Chul Hwan; Jeong, Ki-Heon; Shin, Bong Seok; Kim, Dong Hyun; Song, Hae Jun; Lee, Ju-Hee; Kim, YoungEun; Choi, Sun; Youn, Sang Woong.
Afiliação
  • Jo SJ; Department of Dermatology, Seoul National University College of Medicine, Seoul, South Korea.
  • Park CJ; Department of Dermatology, Seoul National University Hospital, Seoul, South Korea.
  • Bang CH; Department of Dermatology, Bucheon St. Mary's Hospital, The Catholic University of Korea, Bucheon, South Korea.
  • Jeong KH; Department of Dermatology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
  • Shin BS; Department of Dermatology, KyungHee University Medical Center, Seoul, South Korea.
  • Kim DH; Department of Dermatology, Chosun University Hospital, Gwangju, South Korea.
  • Song HJ; Department of Dermatology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South Korea.
  • Lee JH; Department of Dermatology, Chungnam National University Sejong Hospital, Sejong, South Korea.
  • Kim Y; Department of Dermatology, Severance Hospital, Seoul, South Korea.
  • Choi S; LEO Pharma Limited, Seoul, South Korea.
  • Youn SW; LEO Pharma Limited, Seoul, South Korea.
J Dermatol ; 51(7): 1010-1016, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38716641
ABSTRACT
Small plaque psoriasis is the typical form of chronic plaque psoriasis affecting adults in South Korea. The effectiveness of calcipotriol/betamethasone dipropionate (Cal/BD) aerosol foam for large and small psoriasis plaques has not previously been examined. We performed a post hoc analysis of a recent, 4-week observational study of Cal/BD aerosol foam use in routine clinical practice in South Korea. Investigator Global Assessment response ([IGA] 0/1 at week 4), Patient Global Assessment response ([PaGA] 0/1 at week 4), change in Psoriasis Area and Severity Index (PASI), changes in psoriasis symptom scores, change in the Dermatology Life Quality Index (DLQI), and the proportion of patients achieving DLQI ≤5 were analyzed for patients with small (≤5 cm; n = 131) or large (>5 cm; n = 35) baseline plaque size. IGA response rates were similar for patients with small and large plaques (59.5% and 51.4% respectively). Similarly, there was no significant difference between the small and large groups in mean change in PASI (-2.20 vs -3.34), the proportions of patients with DLQI ≤5 (62.3% vs 54.3%) or PaGA 0/1 (29.2% vs 40.0%). Mean improvements in DLQI (-4.04 vs -6.20) and in psoriasis symptoms including itching (-1.50 vs -2.83), sleep loss (-0.67 vs -1.89), dryness (-1.57 vs -2.97), scaling (-1.21 vs -3.57), and redness (-1.17 vs -3.11) were greater in patients with large plaques than those with small plaques. Itching and DLQI differences were not statistically significant after adjustment for baseline characteristics. Stratification by body surface area affected eliminated statistically significant differences between the groups for most outcomes. In conclusion, this analysis suggests that Cal/BD aerosol foam is an effective, well-accepted treatment for adult patients with the small plaques typical of chronic plaque psoriasis in South Korea, as well as for those with large plaques.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Qualidade de Vida / Índice de Gravidade de Doença / Calcitriol / Betametasona / Aerossóis / Fármacos Dermatológicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Qualidade de Vida / Índice de Gravidade de Doença / Calcitriol / Betametasona / Aerossóis / Fármacos Dermatológicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article